Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04637 (
p53
)
77,613
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A novel
target of NESH-SH3
(
TARSH
) was identified as a cellular senescence related gene in mouse embryonic fibroblasts (MEFs) replicative senescence, the expression of which has been suppressed in primary clinical lung cancer specimens. However, the molecular mechanism underlying the regulation of
TARSH
involved in pulmonary tumorigenesis remains unclear. Here we demonstrate that the reduction of
TARSH
gene expression by short hairpin RNA (shRNA) system robustly inhibited the MEFs proliferation with increase in senescence-associated beta-galactosidase (SA-beta-gal) activity. Using
p53
-/- MEFs, we further suggest that this growth arrest by loss of
TARSH
is evoked by
p53
-dependent p21(Cip1) accumulation. Moreover, we also reveal that
TARSH
reduction induces multicentrosome in MEFs, which is linked in chromosome instability and tumor development. These results suggest that
TARSH
plays an important role in proliferation of replicative senescence and may serve as a trigger of tumor development.
...
PMID:Implication of p53-dependent cellular senescence related gene, TARSH in tumor suppression. 1933 57
A
target of NESH-SH3
/Abi3bp (TARSH) was originally identified as an SH3 domain-binding molecule of the NESH-SH3/Abi3 protein that is involved in Rac-dependent actin polymerization. In recent studies, TARSH gene expression was dramatically induced in mouse embryonic fibroblasts (MEFs) replicative senescence and suppressed in human lung carcinoma specimens and thyroid carcinomas. However, the molecular mechanism underlying the regulation of TARSH in tumorigenesis remains unclear. Here, we address a
p53
-dependent apoptosis function of the mouse TARSH gene using RNAi-mediated suppression of endogenous TARSH expression. Our results will be useful in the discovery of a novel therapeutic target in lung carcinoma.
...
PMID:A novel p53-dependent apoptosis function of TARSH in tumor development. 1999 23